Capital International Ltd /Ca/
Source: SEC Form 13F · as of Mar 2026Capital International Ltd /Ca/ holds 17 biotech & pharma companies tracked by BioSniper, totaling $334.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$334.7M
| Company | Shares | Value |
|---|---|---|
| AZNASTRAZENECA PLC | 472,311 | $92.3M |
| LLYELI LILLY & Co | 70,183 | $64.6M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 95,874 | $42.8M |
| RPRXRoyalty Pharma plc | 570,577 | $27.4M |
| ONCBeOne Medicines Ltd. | 76,515 | $22.7M |
| ABTABBOTT LABORATORIES | 134,930 | $13.9M |
| PFEPFIZER INC | 427,700 | $12.0M |
| REGNREGENERON PHARMACEUTICALS, INC. | 13,610 | $10.5M |
| AMGNAMGEN INC | 27,593 | $9.7M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 29,078 | $9.6M |
| ABBVAbbVie Inc. | 40,450 | $8.8M |
| PMPhilip Morris International Inc | 37,392 | $6.2M |
| BMYBRISTOL MYERS SQUIBB CO | 54,885 | $3.3M |
| GRFSGrifols S.A. | 404,486 | $3.2M |
| ICLRICON plc | 24,663 | $2.7M |
| CRSPCRISPR Therapeutics AG | 56,066 | $2.7M |
| ZBHZimmer Biomet Holdings Inc. | 24,782 | $2.2M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.